Monoclonal antibodies in the therapy of experimental neonatal group B streptococcal disease
- 31 January 1992
- journal article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 62 (1) , S87-S91
- https://doi.org/10.1016/0090-1229(92)90046-q
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effect of Fibronectin on IgA-Mediated Uptake of Type III Group B Streptococci by PhagocytesThe Journal of Infectious Diseases, 1990
- Human monoclonal antibodies to group B streptococcus. Reactivity and in vivo protection against multiple serotypes.The Journal of Experimental Medicine, 1988
- Immunoglobulin therapy of neonatal Group B streptococcal infectionsThe Pediatric Infectious Disease Journal, 1988
- Human Monoclonal Antibody with Protective Activity for Escherichia coli K1 and Neisseria meningitidis Group B InfectionsThe Journal of Infectious Diseases, 1987
- Type-Specific Monoclonal Antibody Enhances the Local Phagocytic Response to Group B Streptococcal InfectionThe Journal of Infectious Diseases, 1986
- Fibronectin enhances the opsonic and protective activity of monoclonal and polyclonal antibody against group B streptococci.The Journal of Experimental Medicine, 1984
- Protective efficacy of a modified immune serum globulin in experimental group B streptococcal infectionThe Journal of Pediatrics, 1981
- MODIFIED IMMUNE SERUM GLOBULINThe Lancet, 1981
- BLOOD-TRANSFUSION IN GROUP-B STREPTOCOCCAL SEPSISThe Lancet, 1978
- Immunological Investigation of Infants with Septicemia orMeningitis Due to Group B StreptococcusThe Journal of Infectious Diseases, 1977